Dr Stephen Dobbin

  • Honorary Clinical Research Fellow (School of Cardiovascular & Metabolic Health)

email: Stephen.Dobbin@glasgow.ac.uk

Cardiology Department, Queen Elizabeth University Hospital, Govan Road, Glasgow, G51

Import to contacts

ORCID iDhttps://orcid.org/0000-0002-9111-0242

Publications

List by: Type | Date

Jump to: 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015
Number of items: 15.

2023

Lees, J. S. , Dobbin, S. J.H. , Elyan, B. M.P. , Gilmour, D. F., Tomlinson, L. P., Lang, N. N. and Mark, P. B. (2023) A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes. Nephrology Dialysis Transplantation, 38(7), pp. 1666-1681. (doi: 10.1093/ndt/gfac305) (PMID:36318455) (PMCID:PMC10310520)

Dobbin, S. J.H. , Shen, L., Petrie, M. C. , Packer, M., Solomon, S. D., McMurray, J. J.V. , Lang, N. N. and Jhund, P. S. (2023) Characteristics and outcomes of patients with a history of cancer recruited to heart failure trials. European Journal of Heart Failure, 25(4), pp. 488-496. (doi: 10.1002/ejhf.2818) (PMID:36919816)

2022

Dobbin, S. J.H. , Herrmann, S. M.S., Lang, N. N. , Herrmann, J. and Touyz, R. M. (2022) Hypertension and renal disease before anti-cancer therapies. In: Herrmann, J. (ed.) Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease. Elsevier: Philadelphia, PA, pp. 111-122. ISBN 9780323681353 (doi: 10.1016/B978-0-323-68135-3.00020-9)

Herrmann, S. M.S., Dobbin, S. J.H. , Herrmann, J., Touyz, R. M. and Lang, N. N. (2022) Hypertension and renal disease during anti-cancer therapies. In: Herrmann, J. (ed.) Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease. Elsevier: Philadelphia, PA, pp. 185-199. ISBN 9780323681353 (doi: 10.1016/B978-0-323-68135-3.00029-5)

Lang, N. N. , Dobbin, S. J.H. , Herrmann, S. M.S., Herrmann, J. and Touyz, R. M. (2022) Hypertension and renal failure prevention and management after cancer therapy. In: Herrmann, J. (ed.) Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease. Elsevier: Philadelphia, PA, pp. 286-291. ISBN 9780323681353 (doi: 10.1016/B978-0-323-68135-3.00041-6)

2021

van Dorst, D. C.H., Dobbin, S. J.H. , Neves, K. B. , Herrmann, J., Herrmann, S. M., Versmissen, J., Mathijssen, R. H.J., Danser, A.H. J. and Lang, N. N. (2021) Hypertension and prohypertensive antineoplastic therapies in cancer patients. Circulation Research, 128(7), pp. 1040-1061. (doi: 10.1161/CIRCRESAHA.121.318051) (PMID:33793337) (PMCID:PMC8011349)

Dobbin, S. J.H. , Petrie, M. C. , Myles, R. C. , Touyz, R. M. and Lang, N. N. (2021) Cardiotoxic effects of angiogenesis inhibitors. Clinical Science, 135(1), pp. 71-100. (doi: 10.1042/CS20200305) (PMID:33404052) (PMCID:PMC7812690)

2020

Lang, N. N. , Dobbin, S. J.H. and Petrie, M. C. (2020) Vericiguat in worsening heart failure – agonising over, or celebrating, agonism. Cardiovascular Research, 116(12), e152-e155. (doi: 10.1093/cvr/cvaa247) (PMID:32980877)

Dobbin, S. J.H. et al. (2020) Cardiotoxicity and myocardial hypoperfusion associated with anti-VEGF therapies: prospective cardiac magnetic resonance imaging in patients with cancer. European Journal of Heart Failure, 22(7), pp. 1276-1277. (doi: 10.1002/ejhf.1847) (PMID:32379945)

2018

Dobbin, S. J.H. , Cameron, A. C., Petrie, M. C. , Jones, R. J. , Touyz, R. M. and Lang, N. N. (2018) Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitors. Heart, 104(24), pp. 1995-2002. (doi: 10.1136/heartjnl-2018-313726) (PMID:30228246) (PMCID:PMC6268130)

Evans, J. D.W., Dobbin, S. J.H. , Pettit, S. J., Di Angelantonio, E. and Willeit, P. (2018) High-sensitivity cardiac troponin and new-onset heart failure: a systematic review and meta-analysis of 67,063 patients with 4,165 incident heart failure events. JACC: Heart Failure, 6(3), pp. 187-197. (doi: 10.1016/j.jchf.2017.11.003) (PMID:29331272)

Dobbin, S. , Fisher, M. and McKay, G. (2018) Management of atrial fibrillation in diabetes. Practical Diabetes, 35(1), pp. 27-31. (doi: 10.1002/pdi.2155)

2017

Dobbin, S.J.H. , Petrie, J.R. , Lean, M.E.J. and McKay, G.A. (2017) Fludrocortisone therapy for persistent hyperkalaemia. Diabetic Medicine, 34(7), pp. 1005-1008. (doi: 10.1111/dme.13359) (PMID:28375568)

2016

Dobbin, S. , McKay, G. and Fisher, M. (2016) Aliskiren update. Practical Diabetes, 33(6), pp. 214-215. (doi: 10.1002/pdi.2041)

2015

Badar, A. A. et al. (2015) The management of patients with aortic regurgitation and severe left ventricular dysfunction: a systematic review. Expert Review of Cardiovascular Therapy, 13(8), pp. 915-922. (doi: 10.1586/14779072.2015.1067139) (PMID:26163051)

This list was generated on Thu Nov 21 03:33:38 2024 GMT.
Jump to: Articles | Book Sections
Number of items: 15.

Articles

Lees, J. S. , Dobbin, S. J.H. , Elyan, B. M.P. , Gilmour, D. F., Tomlinson, L. P., Lang, N. N. and Mark, P. B. (2023) A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes. Nephrology Dialysis Transplantation, 38(7), pp. 1666-1681. (doi: 10.1093/ndt/gfac305) (PMID:36318455) (PMCID:PMC10310520)

Dobbin, S. J.H. , Shen, L., Petrie, M. C. , Packer, M., Solomon, S. D., McMurray, J. J.V. , Lang, N. N. and Jhund, P. S. (2023) Characteristics and outcomes of patients with a history of cancer recruited to heart failure trials. European Journal of Heart Failure, 25(4), pp. 488-496. (doi: 10.1002/ejhf.2818) (PMID:36919816)

van Dorst, D. C.H., Dobbin, S. J.H. , Neves, K. B. , Herrmann, J., Herrmann, S. M., Versmissen, J., Mathijssen, R. H.J., Danser, A.H. J. and Lang, N. N. (2021) Hypertension and prohypertensive antineoplastic therapies in cancer patients. Circulation Research, 128(7), pp. 1040-1061. (doi: 10.1161/CIRCRESAHA.121.318051) (PMID:33793337) (PMCID:PMC8011349)

Dobbin, S. J.H. , Petrie, M. C. , Myles, R. C. , Touyz, R. M. and Lang, N. N. (2021) Cardiotoxic effects of angiogenesis inhibitors. Clinical Science, 135(1), pp. 71-100. (doi: 10.1042/CS20200305) (PMID:33404052) (PMCID:PMC7812690)

Lang, N. N. , Dobbin, S. J.H. and Petrie, M. C. (2020) Vericiguat in worsening heart failure – agonising over, or celebrating, agonism. Cardiovascular Research, 116(12), e152-e155. (doi: 10.1093/cvr/cvaa247) (PMID:32980877)

Dobbin, S. J.H. et al. (2020) Cardiotoxicity and myocardial hypoperfusion associated with anti-VEGF therapies: prospective cardiac magnetic resonance imaging in patients with cancer. European Journal of Heart Failure, 22(7), pp. 1276-1277. (doi: 10.1002/ejhf.1847) (PMID:32379945)

Dobbin, S. J.H. , Cameron, A. C., Petrie, M. C. , Jones, R. J. , Touyz, R. M. and Lang, N. N. (2018) Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitors. Heart, 104(24), pp. 1995-2002. (doi: 10.1136/heartjnl-2018-313726) (PMID:30228246) (PMCID:PMC6268130)

Evans, J. D.W., Dobbin, S. J.H. , Pettit, S. J., Di Angelantonio, E. and Willeit, P. (2018) High-sensitivity cardiac troponin and new-onset heart failure: a systematic review and meta-analysis of 67,063 patients with 4,165 incident heart failure events. JACC: Heart Failure, 6(3), pp. 187-197. (doi: 10.1016/j.jchf.2017.11.003) (PMID:29331272)

Dobbin, S. , Fisher, M. and McKay, G. (2018) Management of atrial fibrillation in diabetes. Practical Diabetes, 35(1), pp. 27-31. (doi: 10.1002/pdi.2155)

Dobbin, S.J.H. , Petrie, J.R. , Lean, M.E.J. and McKay, G.A. (2017) Fludrocortisone therapy for persistent hyperkalaemia. Diabetic Medicine, 34(7), pp. 1005-1008. (doi: 10.1111/dme.13359) (PMID:28375568)

Dobbin, S. , McKay, G. and Fisher, M. (2016) Aliskiren update. Practical Diabetes, 33(6), pp. 214-215. (doi: 10.1002/pdi.2041)

Badar, A. A. et al. (2015) The management of patients with aortic regurgitation and severe left ventricular dysfunction: a systematic review. Expert Review of Cardiovascular Therapy, 13(8), pp. 915-922. (doi: 10.1586/14779072.2015.1067139) (PMID:26163051)

Book Sections

Dobbin, S. J.H. , Herrmann, S. M.S., Lang, N. N. , Herrmann, J. and Touyz, R. M. (2022) Hypertension and renal disease before anti-cancer therapies. In: Herrmann, J. (ed.) Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease. Elsevier: Philadelphia, PA, pp. 111-122. ISBN 9780323681353 (doi: 10.1016/B978-0-323-68135-3.00020-9)

Herrmann, S. M.S., Dobbin, S. J.H. , Herrmann, J., Touyz, R. M. and Lang, N. N. (2022) Hypertension and renal disease during anti-cancer therapies. In: Herrmann, J. (ed.) Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease. Elsevier: Philadelphia, PA, pp. 185-199. ISBN 9780323681353 (doi: 10.1016/B978-0-323-68135-3.00029-5)

Lang, N. N. , Dobbin, S. J.H. , Herrmann, S. M.S., Herrmann, J. and Touyz, R. M. (2022) Hypertension and renal failure prevention and management after cancer therapy. In: Herrmann, J. (ed.) Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease. Elsevier: Philadelphia, PA, pp. 286-291. ISBN 9780323681353 (doi: 10.1016/B978-0-323-68135-3.00041-6)

This list was generated on Thu Nov 21 03:33:38 2024 GMT.